Add ‘Speed’ To Your Treatment Tech Planning List

A pill with an ingestible digital sensor to track medication adherence. Medication implants and injectable medications for opioid addiction. New formulations for long-acting injectable medications for schizophrenia. These are just a few of the recent approvals by the Food and Drug Administration (FDA) of new digital treatment technologies (see The Emerging Digital Treatment Era) and innovative medication formulations in the complex consumer space (see Predicting The Future Of Medications-More Options & More Medication Adherence). This is a whole new wave of treatment options available to consumers.

For executives of provider organizations and health plans, this continual stream of . . .